Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes

Benjamin J. Burwitz, Helen L. Wu, Shaheed Abdulhaqq, Christine Shriver-Munsch, Tonya Swanson, Alfred W. Legasse, Katherine B. Hammond, Stephanie L. Junell, Jason S. Reed, Benjamin N. Bimber, Justin M. Greene, Gabriela M. Webb, Mina Northrup, Wolfram Laub, Paul Kievit, Rhonda MacAllister, Michael K. Axthelm, Rebecca Ducore, Anne Lewis, Lois M.A. ColginTheodore Hobbs, Lauren D. Martin, Betsy Ferguson, Charles R. Thomas, Angela Panoskaltsis-Mortari, Gabrielle Meyers, Jeffrey J. Stanton, Richard T. Maziarz, Jonah B. Sacha

Research output: Contribution to journalArticle

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) is a critically important therapy for hematological malignancies, inborn errors of metabolism, and immunodeficiency disorders, yet complications such as graft-vs.-host disease (GvHD) limit survival. Development of anti-GvHD therapies that do not adversely affect susceptibility to infection or graft-vs.-Tumor immunity are hampered by the lack of a physiologically relevant, preclinical model of allogeneic HSCT. Here we show a spectrum of diverse clinical HSCT outcomes including primary and secondary graft failure, lethal GvHD, and stable, disease-free full donor engraftment using reduced intensity conditioning and mobilized peripheral blood HSCT in unrelated, fully MHC-matched Mauritian-origin cynomolgus macaques. Anti-GvHD prophylaxis of tacrolimus, post-Transplant cyclophosphamide, and CD28 blockade induces multi-lineage, full donor chimerism and recipient-specific tolerance while maintaining pathogen-specific immunity. These results establish a new preclinical allogeneic HSCT model for evaluation of GvHD prophylaxis and next-generation HSCT-mediated therapies for solid organ tolerance, cure of non-malignant hematological disease, and HIV reservoir clearance.

Original languageEnglish (US)
Article number1418
JournalNature Communications
Volume8
Issue number1
DOIs
StatePublished - Dec 1 2017
Externally publishedYes

Fingerprint

transplantation
stem cells
Hematopoietic Stem Cell Transplantation
Macaca
Stem Cell Transplantation
Stem cells
prophylaxis
Grafts
Transplants
therapy
immunity
Immunity
Disease Reservoirs
Peripheral Blood Stem Cell Transplantation
Inborn Errors Metabolism
Chimerism
human immunodeficiency virus
pathogens
Hematologic Diseases
clearances

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

Burwitz, B. J., Wu, H. L., Abdulhaqq, S., Shriver-Munsch, C., Swanson, T., Legasse, A. W., ... Sacha, J. B. (2017). Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes. Nature Communications, 8(1), [1418]. https://doi.org/10.1038/s41467-017-01631-z

Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes. / Burwitz, Benjamin J.; Wu, Helen L.; Abdulhaqq, Shaheed; Shriver-Munsch, Christine; Swanson, Tonya; Legasse, Alfred W.; Hammond, Katherine B.; Junell, Stephanie L.; Reed, Jason S.; Bimber, Benjamin N.; Greene, Justin M.; Webb, Gabriela M.; Northrup, Mina; Laub, Wolfram; Kievit, Paul; MacAllister, Rhonda; Axthelm, Michael K.; Ducore, Rebecca; Lewis, Anne; Colgin, Lois M.A.; Hobbs, Theodore; Martin, Lauren D.; Ferguson, Betsy; Thomas, Charles R.; Panoskaltsis-Mortari, Angela; Meyers, Gabrielle; Stanton, Jeffrey J.; Maziarz, Richard T.; Sacha, Jonah B.

In: Nature Communications, Vol. 8, No. 1, 1418, 01.12.2017.

Research output: Contribution to journalArticle

Burwitz, BJ, Wu, HL, Abdulhaqq, S, Shriver-Munsch, C, Swanson, T, Legasse, AW, Hammond, KB, Junell, SL, Reed, JS, Bimber, BN, Greene, JM, Webb, GM, Northrup, M, Laub, W, Kievit, P, MacAllister, R, Axthelm, MK, Ducore, R, Lewis, A, Colgin, LMA, Hobbs, T, Martin, LD, Ferguson, B, Thomas, CR, Panoskaltsis-Mortari, A, Meyers, G, Stanton, JJ, Maziarz, RT & Sacha, JB 2017, 'Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes', Nature Communications, vol. 8, no. 1, 1418. https://doi.org/10.1038/s41467-017-01631-z
Burwitz, Benjamin J. ; Wu, Helen L. ; Abdulhaqq, Shaheed ; Shriver-Munsch, Christine ; Swanson, Tonya ; Legasse, Alfred W. ; Hammond, Katherine B. ; Junell, Stephanie L. ; Reed, Jason S. ; Bimber, Benjamin N. ; Greene, Justin M. ; Webb, Gabriela M. ; Northrup, Mina ; Laub, Wolfram ; Kievit, Paul ; MacAllister, Rhonda ; Axthelm, Michael K. ; Ducore, Rebecca ; Lewis, Anne ; Colgin, Lois M.A. ; Hobbs, Theodore ; Martin, Lauren D. ; Ferguson, Betsy ; Thomas, Charles R. ; Panoskaltsis-Mortari, Angela ; Meyers, Gabrielle ; Stanton, Jeffrey J. ; Maziarz, Richard T. ; Sacha, Jonah B. / Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes. In: Nature Communications. 2017 ; Vol. 8, No. 1.
@article{8d94d5f39bab49638cea54fb81e3e0be,
title = "Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes",
abstract = "Allogeneic hematopoietic stem cell transplantation (HSCT) is a critically important therapy for hematological malignancies, inborn errors of metabolism, and immunodeficiency disorders, yet complications such as graft-vs.-host disease (GvHD) limit survival. Development of anti-GvHD therapies that do not adversely affect susceptibility to infection or graft-vs.-Tumor immunity are hampered by the lack of a physiologically relevant, preclinical model of allogeneic HSCT. Here we show a spectrum of diverse clinical HSCT outcomes including primary and secondary graft failure, lethal GvHD, and stable, disease-free full donor engraftment using reduced intensity conditioning and mobilized peripheral blood HSCT in unrelated, fully MHC-matched Mauritian-origin cynomolgus macaques. Anti-GvHD prophylaxis of tacrolimus, post-Transplant cyclophosphamide, and CD28 blockade induces multi-lineage, full donor chimerism and recipient-specific tolerance while maintaining pathogen-specific immunity. These results establish a new preclinical allogeneic HSCT model for evaluation of GvHD prophylaxis and next-generation HSCT-mediated therapies for solid organ tolerance, cure of non-malignant hematological disease, and HIV reservoir clearance.",
author = "Burwitz, {Benjamin J.} and Wu, {Helen L.} and Shaheed Abdulhaqq and Christine Shriver-Munsch and Tonya Swanson and Legasse, {Alfred W.} and Hammond, {Katherine B.} and Junell, {Stephanie L.} and Reed, {Jason S.} and Bimber, {Benjamin N.} and Greene, {Justin M.} and Webb, {Gabriela M.} and Mina Northrup and Wolfram Laub and Paul Kievit and Rhonda MacAllister and Axthelm, {Michael K.} and Rebecca Ducore and Anne Lewis and Colgin, {Lois M.A.} and Theodore Hobbs and Martin, {Lauren D.} and Betsy Ferguson and Thomas, {Charles R.} and Angela Panoskaltsis-Mortari and Gabrielle Meyers and Stanton, {Jeffrey J.} and Maziarz, {Richard T.} and Sacha, {Jonah B.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41467-017-01631-z",
language = "English (US)",
volume = "8",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Allogeneic stem cell transplantation in fully MHC-matched Mauritian cynomolgus macaques recapitulates diverse human clinical outcomes

AU - Burwitz, Benjamin J.

AU - Wu, Helen L.

AU - Abdulhaqq, Shaheed

AU - Shriver-Munsch, Christine

AU - Swanson, Tonya

AU - Legasse, Alfred W.

AU - Hammond, Katherine B.

AU - Junell, Stephanie L.

AU - Reed, Jason S.

AU - Bimber, Benjamin N.

AU - Greene, Justin M.

AU - Webb, Gabriela M.

AU - Northrup, Mina

AU - Laub, Wolfram

AU - Kievit, Paul

AU - MacAllister, Rhonda

AU - Axthelm, Michael K.

AU - Ducore, Rebecca

AU - Lewis, Anne

AU - Colgin, Lois M.A.

AU - Hobbs, Theodore

AU - Martin, Lauren D.

AU - Ferguson, Betsy

AU - Thomas, Charles R.

AU - Panoskaltsis-Mortari, Angela

AU - Meyers, Gabrielle

AU - Stanton, Jeffrey J.

AU - Maziarz, Richard T.

AU - Sacha, Jonah B.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Allogeneic hematopoietic stem cell transplantation (HSCT) is a critically important therapy for hematological malignancies, inborn errors of metabolism, and immunodeficiency disorders, yet complications such as graft-vs.-host disease (GvHD) limit survival. Development of anti-GvHD therapies that do not adversely affect susceptibility to infection or graft-vs.-Tumor immunity are hampered by the lack of a physiologically relevant, preclinical model of allogeneic HSCT. Here we show a spectrum of diverse clinical HSCT outcomes including primary and secondary graft failure, lethal GvHD, and stable, disease-free full donor engraftment using reduced intensity conditioning and mobilized peripheral blood HSCT in unrelated, fully MHC-matched Mauritian-origin cynomolgus macaques. Anti-GvHD prophylaxis of tacrolimus, post-Transplant cyclophosphamide, and CD28 blockade induces multi-lineage, full donor chimerism and recipient-specific tolerance while maintaining pathogen-specific immunity. These results establish a new preclinical allogeneic HSCT model for evaluation of GvHD prophylaxis and next-generation HSCT-mediated therapies for solid organ tolerance, cure of non-malignant hematological disease, and HIV reservoir clearance.

AB - Allogeneic hematopoietic stem cell transplantation (HSCT) is a critically important therapy for hematological malignancies, inborn errors of metabolism, and immunodeficiency disorders, yet complications such as graft-vs.-host disease (GvHD) limit survival. Development of anti-GvHD therapies that do not adversely affect susceptibility to infection or graft-vs.-Tumor immunity are hampered by the lack of a physiologically relevant, preclinical model of allogeneic HSCT. Here we show a spectrum of diverse clinical HSCT outcomes including primary and secondary graft failure, lethal GvHD, and stable, disease-free full donor engraftment using reduced intensity conditioning and mobilized peripheral blood HSCT in unrelated, fully MHC-matched Mauritian-origin cynomolgus macaques. Anti-GvHD prophylaxis of tacrolimus, post-Transplant cyclophosphamide, and CD28 blockade induces multi-lineage, full donor chimerism and recipient-specific tolerance while maintaining pathogen-specific immunity. These results establish a new preclinical allogeneic HSCT model for evaluation of GvHD prophylaxis and next-generation HSCT-mediated therapies for solid organ tolerance, cure of non-malignant hematological disease, and HIV reservoir clearance.

UR - http://www.scopus.com/inward/record.url?scp=85033605955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033605955&partnerID=8YFLogxK

U2 - 10.1038/s41467-017-01631-z

DO - 10.1038/s41467-017-01631-z

M3 - Article

C2 - 29127275

AN - SCOPUS:85033605955

VL - 8

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

IS - 1

M1 - 1418

ER -